Korean bone implant product passed through FDA's pre-marketing review.
Published: 2004-06-28 06:58:00
Updated: 2004-06-28 06:58:00
Oscotech locally developed BBP, a dental bone implant material, in 1999 and obtained the approval of the U.S. FDA's 510K (Pre-marketing review notification), which was the 2nd event in passing through the U. S. FDA's review after the dental implant.
Oscotech said "The quality system of BBP was...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
